Diffuse follicle center lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of neoplastic B-cells in the lymph nodes, particularly affecting intra-abdominal lymph nodes. This condition is clinically significant due to its potential for aggressive behavior and the need for accurate diagnosis and treatment. The ICD-10 Code C82.53 facilitates precise documentation, billing, and public health reporting, ensuring that healthcare providers can effectively manage patient care.
ICD-10 Code C82.53 represents Diffuse follicle center lymphoma localized in the intra-abdominal lymph nodes. This condition arises from the malignant transformation of follicle center B-cells and is associated with various clinical manifestations. The code should be used in clinical documentation and billing when diagnosing patients with this specific type of lymphoma, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.
Diffuse follicle center lymphoma, particularly affecting intra-abdominal lymph nodes, is a hematological malignancy that requires prompt medical attention due to its aggressive nature and potential complications. The condition is characterized by the uncontrolled growth of B-lymphocytes, leading to lymphadenopathy and systemic symptoms. Early diagnosis and treatment are crucial for improving patient outcomes.
ICD-10 Code C82.53 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients diagnosed with diffuse follicle center lymphoma affecting intra-abdominal lymph nodes. This code plays a vital role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and guiding clinical decision-making.
In SOAP notes, ICD-10 Code C82.53 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of diffuse follicle center lymphoma. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting electronic health record documentation standards.
The management of diffuse follicle center lymphoma affecting intra-abdominal lymph nodes often necessitates hospitalization for intensive treatment and monitoring. Treatment approaches may include chemotherapy, immunotherapy, or targeted therapy, depending on the disease stage and patient factors.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C82.53 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings, ensuring accurate representation of the patient's diagnosis.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 85025 | Complete blood count (CBC) with automated differential white blood cell count. |
| 77014 | Radiologic examination, lymphatic system, including lymphangiography. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Common Questions About Using ICD-10 Code C82.53 for Diffuse follicle center lymphoma, intra-abd lymph nodes
What are the common symptoms of diffuse follicle center lymphoma?
Common symptoms include abdominal pain, unexplained weight loss, night sweats, and fatigue. Patients may also experience lymphadenopathy and systemic signs of illness.
How is diffuse follicle center lymphoma diagnosed?
Diagnosis typically involves imaging studies, biopsy of affected lymph nodes, and laboratory tests to assess blood counts and markers associated with lymphoma.
What treatment options are available for this condition?
Treatment may include chemotherapy, immunotherapy, and targeted therapies. Supportive care is also essential to manage symptoms and improve quality of life.
Is diffuse follicle center lymphoma curable?
While some patients achieve remission with treatment, the prognosis varies based on factors such as disease stage and patient health. Ongoing monitoring is crucial.
Clinical Notes
SOAP notes
DAP notes
AI medical notes